What the MCCQE tests in mood and anxiety disorders
Mood and anxiety questions are among the most practical items on the MCCQE. The exam is not interested in rare syndromes. It wants to know whether a new physician can recognize depression in a busy clinic, can tell when low mood is really bipolar disorder, can judge whether a patient is safe to go home, and can choose a sensible first treatment that matches Canadian guidance.
Questions are spread across the MCC blueprint. Acute care items put you in the emergency department with a patient who took an overdose or who cannot stop shaking with panic. Chronic care items follow a patient whose depression has only partly responded after several weeks. Health promotion and illness prevention appear as screening for perinatal depression and as relapse prevention. Psychosocial care runs through all of them, because work, money, relationships and violence at home change both the risk and the plan.
On the physician activities side, assessment items ask for the diagnosis or the most useful test, management items ask for the next step or the first-line drug, and communication and professional behaviour items test how you ask about suicide, how you involve family with consent, and when you may act without consent under a provincial mental health act.
- Assessment: DSM-5-TR criteria, ruling out medical and substance causes, screening for mania before treating depression
- Management: first-line psychotherapy and medication, how long to continue, what to do after a partial response
- Safety: suicide risk formulation, means restriction, admission decisions
- Special groups: youth, pregnancy and the postpartum period, older adults
Major depressive disorder: the decision points that score
The diagnosis needs at least five of the nine DSM-5-TR symptoms for at least two weeks, and one of them must be depressed mood or loss of interest. The symptoms must cause distress or impairment and must not be better explained by a substance, a medical condition or a psychotic disorder. Stems often hide the cause in the history: a new beta blocker, heavy alcohol use, weight gain with cold intolerance, or a recent stroke.
Before you treat, three questions decide the answer. Is the patient safe? Has the patient ever had a manic or hypomanic episode? Is there a medical cause to exclude? A basic work-up in primary care is guided by the history, and thyroid function and a complete blood count are reasonable when the picture suggests them. Imaging is not routine.
For mild depression, CANMAT supports psychotherapy such as cognitive behavioural therapy, interpersonal therapy or behavioural activation, along with exercise and self-management, as first-line options. For moderate to severe depression, an antidepressant, an evidence-based psychotherapy, or both, are appropriate. CANMAT lists several first-line antidepressants, including SSRIs, SNRIs, bupropion, mirtazapine and vortioxetine. The exam rarely needs one specific drug. It needs you to pick a first-line agent, to warn about early side effects, and to plan follow-up within about two weeks.
Response is judged after an adequate dose for an adequate time. If there is little improvement after two to four weeks at a therapeutic dose, the guideline supports optimizing the dose, switching, or adding an adjunct. Once remission is reached, treatment continues for months, not weeks: CANMAT recommends continuing for at least six to twelve months after remission, and longer for people with recurrent episodes or other risk factors. Stopping the drug as soon as the patient feels better is a classic wrong answer.
Electroconvulsive therapy is the right answer when depression is psychotic, when the patient has stopped eating or drinking, when catatonia is present, or when acute suicide risk is high and a fast response is needed. Psychotic depression treated with an antidepressant alone is undertreated: it needs an antidepressant with an antipsychotic, or ECT.
- Ask about past mania or hypomania and family history of bipolar disorder before every antidepressant start
- Health Canada warns about increased suicidal thinking with antidepressants in children, adolescents and young adults: monitor closely in the first weeks
- Older adults: start low, check sodium if confusion appears on an SSRI, and watch for falls
- Persistent depressive disorder means at least two years of depressed mood in adults
First visit for low mood: the decision path
- 1Assess safetyAsk directly about suicidal thoughts, plan, intent, means and past attempts. Unsafe means urgent action before any prescription.
- 2Screen for mania or hypomaniaAsk about past periods of little sleep without fatigue, risky spending or racing thoughts, and family history of bipolar disorder.
- 3Exclude medical and substance causesReview drugs, alcohol and cannabis. Use history-led tests such as TSH and CBC. Imaging is not routine.
- 4Confirm diagnosis and severityFive of nine symptoms for two weeks with impairment. Note psychotic features, which change the treatment.
- 5Choose first-line careMild: psychotherapy, exercise, self-management. Moderate to severe: antidepressant, psychotherapy or both.
- 6Follow up and continueReview within about 2 weeks. Adjust after 2 to 4 weeks with little change. Continue 6 to 12 months after remission.
Bipolar disorder: recognizing it and treating it safely
Mania needs at least one week of elevated, expansive or irritable mood with increased energy, or any duration if the patient is admitted. Hypomania needs at least four days and does not cause marked impairment or psychosis. Bipolar I needs one manic episode. Bipolar II needs at least one hypomanic and one major depressive episode. Exam stems give you the clue in a past episode of little sleep without fatigue, rapid speech, spending or risky behaviour.
For acute mania, the CANMAT and ISBD guideline lists lithium, quetiapine, divalproex and several second-generation antipsychotics as first-line monotherapy, and supports combining lithium or divalproex with an antipsychotic for more severe mania. Stop any antidepressant. Agitated or psychotic mania may need a safe setting and, if the patient lacks insight and is at risk, involuntary admission.
For bipolar depression, the first-line options in that guideline include quetiapine, lurasidone, lithium and lamotrigine. Antidepressant monotherapy is not recommended in bipolar I because of the risk of switching into mania and of mood destabilization.
Lithium is a favourite exam drug. It needs baseline and ongoing kidney function, thyroid function and calcium, plus regular serum levels. Toxicity causes coarse tremor, vomiting, diarrhea, ataxia, confusion and, in severe cases, seizures. Common triggers are dehydration, thiazide diuretics, ACE inhibitors, angiotensin receptor blockers and NSAIDs. Valproate is highly teratogenic and is avoided in people who could become pregnant unless no alternative works and effective contraception is in place.
Anxiety disorders, OCD and PTSD
Generalized anxiety disorder means excessive, hard-to-control worry about many things on most days for at least six months, with physical symptoms such as poor sleep, muscle tension and fatigue. Panic disorder is recurrent unexpected panic attacks followed by at least a month of worry about more attacks or changed behaviour. Social anxiety disorder is fear of scrutiny that leads to avoidance. Before you label any of these, exclude hyperthyroidism, stimulant or caffeine use, alcohol or benzodiazepine withdrawal, and, in an older patient with first-ever panic, a cardiac or respiratory cause.
The Canadian anxiety guideline places CBT and SSRIs or SNRIs as first-line options for the main anxiety disorders. Benzodiazepines are second-line and are best kept short term because of dependence, falls, cognitive effects and the danger of combining them with alcohol or opioids. An exam answer that starts a long-term benzodiazepine for a new diagnosis of GAD is almost always wrong.
Obsessive-compulsive disorder is treated with CBT that includes exposure and response prevention, and with SSRIs. OCD often needs higher SSRI doses and a longer trial before response than depression does. Clomipramine is an alternative. Body dysmorphic disorder and hoarding sit in the same chapter of DSM-5-TR and appear occasionally.
PTSD needs exposure to a traumatic event followed by intrusions, avoidance, negative changes in mood or thinking, and arousal for more than a month. Symptoms in the first month after the event suggest acute stress disorder. Trauma-focused psychotherapies, such as prolonged exposure, cognitive processing therapy and EMDR, are first-line, and SSRIs or venlafaxine are first-line medications. Benzodiazepines are not recommended for PTSD and may worsen outcomes.
- Panic attack plus chest pain in a 55-year-old smoker: rule out cardiac disease before calling it panic
- New anxiety with weight loss and tremor: check TSH
- Trauma history: ask about current safety, including intimate partner violence
Suicide risk assessment and the admission decision
Asking directly about suicide does not plant the idea. The MCCQE expects you to ask about thoughts, intent, plan, means, preparation, past attempts and what keeps the patient going. Risk factors include a past attempt, male sex in middle and older age, older age, living alone, chronic pain or illness, substance use, recent loss, and access to lethal means. Protective factors include strong relationships, children at home, faith or reasons for living, and engagement with care.
The exam does not want a numeric risk score. It wants a formulation that leads to an action. Low risk with good supports may go home with a safety plan, means restriction, a follow-up date and crisis resources. A patient with a plan, intent, access to means or a recent serious attempt needs urgent psychiatric assessment, and if they will not stay, the physician must consider the criteria of the provincial mental health act for involuntary assessment.
Means restriction is one of the most effective steps. Ask about firearms in the home and about stockpiled medications, and involve family with the patient's consent or, where safety requires it, without consent within the limits of privacy law. In Canada, the 9-8-8 Suicide Crisis Helpline gives phone and text support across the country, and the exam may expect you to provide crisis resources at discharge.
- Overdose of acetaminophen: medical care first, then psychiatric assessment once medically stable
- Intoxicated patient expressing suicidal ideas: reassess when sober before deciding on discharge
- Never discharge a high-risk patient simply because they refuse admission
Red flags that change the answer
Perinatal mental health
Postpartum blues are common, start in the first few days after birth and settle within about two weeks without treatment. Reassure and follow up. Postpartum depression meets criteria for a major depressive episode with onset in pregnancy or after delivery and needs treatment, with screening tools such as the Edinburgh Postnatal Depression Scale used in many Canadian settings.
Postpartum psychosis is a psychiatric emergency. It usually begins within the first few weeks after delivery, often with confusion, rapidly changing mood, insomnia and delusions about the baby. Many of these patients have bipolar disorder. The correct next step is urgent psychiatric assessment and admission, with the baby kept safe and never left alone with the mother until risk is assessed. Ask about thoughts of harming the infant.
Medication decisions in pregnancy and breastfeeding weigh the risk of untreated illness against drug exposure. Many SSRIs are used in pregnancy and lactation after a shared discussion, and sertraline is often chosen during breastfeeding. Valproate should be avoided. Lithium may be continued in some patients with specialist input and closer monitoring around delivery. On the exam, stopping a needed antidepressant abruptly because the patient is pregnant is usually the wrong answer.
Canadian practice points and differences from US resources
Use Canadian guidance. CANMAT publishes the depression and bipolar guidelines that Canadian family physicians and psychiatrists use, and Canadian anxiety, PTSD and OCD guidelines exist as well. US-based question banks often follow American Psychiatric Association guidance and US drug labelling, and the answers usually agree, but the reasoning and the drug lists differ at the edges.
Involuntary admission is governed by provincial and territorial mental health acts, not by one national law. The criteria, forms and time limits vary by province, so the MCCQE tests the principle: a patient with a mental disorder who is at serious risk of harm to self or others, or of serious deterioration in some provinces, can be held for assessment, and must be told their rights. US terms such as a state psychiatric hold do not apply.
Crisis resources are Canadian: 9-8-8 for suicide crisis support, provincial health lines, and local mobile crisis teams. Publicly funded psychotherapy access varies by province, so a strong answer often pairs a referral with something the family physician can start now, such as behavioural activation, structured problem-solving or an internet-delivered CBT program.
Canadian framing vs common US resource habits
Canadian practice (MCCQE)
- CANMAT guidelines for depression and bipolar disorder
- Provincial and territorial mental health acts for involuntary assessment
- 9-8-8 Suicide Crisis Helpline by phone or text
- Health Canada safety warnings and product monographs
- Psychotherapy access varies by province, so start what you can in primary care
Common US resource habit
- American Psychiatric Association guidance as the main reference
- State-specific psychiatric hold rules and terms
- US crisis line numbers and US insurance pathways
- FDA labelling language and boxed warning wording
- Assumes referral to private therapy covered by insurance
How the MCCQE frames this topic: three mini cases
Case one. A 44-year-old teacher tells her family physician she has felt flat for a month, wakes at 4 a.m. and has lost 4 kg without trying. The options list three antidepressants, a referral to psychiatry and a question about suicidal thoughts. The marks go to the safety question first. The exam is checking whether you assess risk before you prescribe, because the right drug for an unsafe patient is still the wrong next step.
Case two. A 23-year-old man has been treated with an SSRI for six weeks for depression. His roommate brings him in because he has slept two hours a night for five days, talks fast and has spent his rent on online purchases. The best answer stops the antidepressant and starts a first-line antimanic agent. The item tests two things at once: that you recognize treatment-emergent mania, and that you now treat him as bipolar disorder, not as a side effect to watch.
Case three. A 66-year-old man with no psychiatric history has his first-ever panic attack with chest tightness and sweating while shovelling snow. One option is an SSRI and CBT referral. Another is an ECG and troponin. The exam wants the cardiac work-up. New panic in an older adult with vascular risk is a medical problem until proven otherwise, and the psychiatric label comes only after that.
- Safety first, drug second
- Mania on an antidepressant: stop it, treat as bipolar
- New anxiety in an older adult: medical cause first
Medical mimics, drug reactions and lab points
Many mood and anxiety stems are really medicine items. Hypothyroidism, anemia, vitamin B12 deficiency, obstructive sleep apnea, Parkinson disease, stroke, cancer of the pancreas, Cushing syndrome and corticosteroid use can all present with low mood. Hyperthyroidism, pheochromocytoma, hypoglycemia, arrhythmias, asthma and stimulant or caffeine use can mimic anxiety. Alcohol and benzodiazepine withdrawal produce anxiety, tremor and insomnia that look like a primary anxiety disorder. Use the history to choose tests: TSH, CBC, glucose, electrolytes and a urine drug screen are common, targeted choices.
Two drug emergencies come up often. Serotonin syndrome follows a new serotonergic drug or a combination, for example an SSRI with tramadol, linezolid, triptans or an MAOI. It starts within hours to a day and shows agitation, fever, sweating, diarrhea, tremor, hyperreflexia and inducible clonus that is most marked in the legs. Stop the drugs, give supportive care and benzodiazepines, and consider cyproheptadine in moderate cases. Neuroleptic malignant syndrome follows an antipsychotic, develops over days, and shows lead-pipe rigidity, fever, altered mental status and a high creatine kinase with slow, reduced reflexes. Both are urgent, and the stem usually separates them by the time course and the reflexes.
Hyponatremia from SIADH is a known SSRI and SNRI effect, especially in older adults and people on diuretics. Confusion or falls in the first weeks of treatment should prompt a sodium level. SSRIs also add bleeding risk with anticoagulants, antiplatelets and NSAIDs. Abrupt stopping of a short half-life SSRI or venlafaxine causes discontinuation symptoms such as dizziness, irritability, flu-like feelings and electric shock sensations, so taper when stopping.
- Serotonin syndrome: hours, clonus, hyperreflexia, diarrhea
- NMS: days, rigidity, slow reflexes, high creatine kinase
- Confused older adult on a new SSRI: check sodium
- Lithium: baseline and follow-up creatinine, eGFR, TSH and calcium, plus serum levels
Youth, older adults and other groups the exam likes
In children and adolescents, depression may look like irritability, school decline or withdrawal from friends rather than sadness. See the young person alone for part of the visit and explain the limits of confidentiality before you ask about self-harm, substance use and abuse. Psychotherapy is the starting point for milder illness. When medication is needed, fluoxetine has the strongest evidence in this age group, and Health Canada's warning means close follow-up in the first weeks for new or worse suicidal thinking or agitation.
In older adults, depression often presents with physical complaints, poor memory, weight loss or withdrawal. Distinguish it from delirium (acute, fluctuating attention) and from dementia (gradual, progressive). Depression can coexist with both. Older men living alone with chronic illness carry a high suicide risk, so ask directly even when the visit is about something else. Start drugs low, watch sodium and falls, and avoid strongly anticholinergic agents such as tricyclics where possible.
Other groups bring their own cues. Indigenous patients may want care that respects family and community and may have experienced trauma linked to residential schools and colonial policies, so a trauma-informed, culturally safe approach is part of the expected answer. Newcomers and refugees may present with somatic complaints, sleep problems or PTSD after war or torture, and may need a professional interpreter rather than a family member. Health care workers and physicians with depression deserve the same confidential care, with provincial physician health programs as a resource.
Communication and ethics: what earns the marks
Communication items test how you ask, not only what you ask. Use direct, non-judgemental questions about suicide, such as asking whether things have got so bad that the patient has thought about ending their life. Normalize the question, then go step by step through thoughts, plan, means, intent and past attempts. Avoid leading questions that invite a no, such as asking that they are not thinking of hurting themselves.
Confidentiality has clear limits that the exam expects you to know. You may disclose without consent when there is a serious and imminent risk of harm to the patient or to an identifiable person, and only the information needed to reduce the risk. Most provinces allow or require reporting of a child in need of protection, so a parent's disclosure that a child is unsafe at home overrides privacy. CMPA advice for physicians stresses documenting your reasons whenever you break confidentiality.
Capacity is decision-specific. A patient with depression may still be capable of refusing a medication, and the exam rewards an assessment of understanding and appreciation rather than an assumption. Involuntary admission under a mental health act does not automatically allow treatment without consent: in most provinces treatment decisions follow a separate capacity and substitute decision-maker process. When a patient refuses admission but meets criteria, the right answer is to follow the act, explain their rights and the reasons, and keep them safe while it is done.
- Ask about suicide directly and without judgement
- Disclose without consent only for serious, imminent risk, and only what is needed
- Detention and treatment are separate decisions in most provinces
- Document reasons whenever you override confidentiality or consent
How mood and anxiety show up in NAC stations
If you will also sit the NAC Examination, expect mood and anxiety in history and counselling stations. A typical history station gives a patient who is tired, not sleeping or not coping at work. Strong candidates screen for depression, mania, psychosis, anxiety and substance use, ask directly about suicide and safety at home, and cover medical causes and medications in the same eleven minutes. Examiners look for an explicit risk statement at the end, not just a list of questions.
Counselling stations may ask you to explain a new diagnosis of depression and starting an SSRI, or to discuss lithium monitoring with a patient who has bipolar disorder. Cover what the medication does, when to expect benefit, common early side effects, the need to keep taking it after feeling better, warning signs that need a call, and crisis resources such as 9-8-8. The oral questions at the 8-minute signal often ask for a first-line drug, a differential diagnosis, or what you would do if the patient expressed a plan to end their life.
- Close a history station with a spoken risk formulation
- In counselling, check understanding with teach-back
- Know one first-line drug and one first-line therapy for each disorder
How to read mood and anxiety stems
Look first for safety. Any mention of a plan, a gun, a recent attempt, psychosis, not eating, or a newborn at home changes the answer from routine care to urgent action. Then look for the hidden bipolar clue: a past period of little sleep without fatigue, a spending spree or a family history. Then look for a medical or substance cause: thyroid symptoms, new drugs, alcohol, cannabis or stimulants.
Watch the lead-in. 'Most appropriate next step' in an unsafe patient is usually an assessment or a safety action, not a drug. 'Most appropriate pharmacotherapy' expects a first-line drug that fits the diagnosis and the patient. 'Most appropriate initial investigation' rarely means imaging. When two answers are both reasonable, the one that follows Canadian first-line guidance and keeps the patient safe is the better choice.
- Partial response at four weeks on a therapeutic dose: optimize, switch or augment, do not wait months
- Remission reached: continue treatment for at least six to twelve months
- Bipolar depression: avoid antidepressant monotherapy
- Anxiety: CBT and SSRI or SNRI before benzodiazepines
A one-week revision plan for mood and anxiety
This plan assumes about 90 minutes a day. Day 1: DSM-5-TR duration rules for depression, persistent depressive disorder, mania, hypomania, GAD, panic, PTSD and acute stress disorder, written from memory. Day 2: unipolar depression management, including first-line choices, how to judge response and how long to continue. Day 3: bipolar disorder, lithium monitoring and toxicity, and treatment-emergent mania. Day 4: anxiety, OCD and PTSD, with first-line therapy and the benzodiazepine traps.
Day 5: suicide risk assessment, means restriction, mental health act principles and confidentiality limits, practised aloud. Day 6: perinatal mental health, youth and older adults, serotonin syndrome versus NMS. Day 7: a timed mixed block of mood and anxiety questions in this question bank, followed by a full review of every explanation and a short list of the decisions you still hesitate over.
| Condition | Key diagnostic point | First-line approach | Exam trap |
|---|---|---|---|
| Major depressive disorder | 5 of 9 symptoms for 2 weeks, including low mood or anhedonia | Psychotherapy and/or a first-line antidepressant | Stopping treatment at remission |
| Psychotic depression | Depression with delusions or hallucinations | Antidepressant plus antipsychotic, or ECT | Antidepressant alone |
| Bipolar I, acute mania | 1 week of mania or any duration with admission | Lithium, quetiapine, divalproex or another first-line agent | Continuing an antidepressant |
| Bipolar depression | Depression in a patient with past mania or hypomania | Quetiapine, lurasidone, lithium or lamotrigine | SSRI monotherapy |
| Generalized anxiety disorder | Uncontrollable worry for 6 months with physical symptoms | CBT and SSRI or SNRI | Long-term benzodiazepine |
| Panic disorder | Unexpected attacks plus 1 month of worry or avoidance | CBT and SSRI or SNRI | Missing a cardiac or thyroid cause |
| OCD | Obsessions and compulsions that take time or cause distress | CBT with ERP and SSRI, often higher dose | Judging response too early |
| PTSD | Trauma, then symptoms lasting over 1 month | Trauma-focused therapy; SSRI or venlafaxine | Benzodiazepines |
| Postpartum psychosis | Confusion and psychosis in the first weeks after birth | Urgent admission and infant safety | Labelling it postpartum blues |
Worked examples in MCCQE style
Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for mood & anxiety disorders.
Example 1
A 27-year-old woman sees her family physician for low mood, poor sleep, guilt and loss of interest for five weeks. She denies suicidal thoughts. Two years ago she had six days in which she slept 3 hours a night without feeling tired, started several projects and spent much of her savings. She did not need admission. TSH and CBC are normal. She takes no medications.
What is the most appropriate pharmacotherapy?
-
An SSRI alone in a patient with past mania risks a switch into mania and does not treat bipolar depression well.
-
Her past episode lasted six days with high spending and no need for sleep, which fits bipolar disorder. Quetiapine is a first-line option for bipolar depression in the CANMAT and ISBD guideline.
-
Bupropion is a first-line drug for unipolar depression, but antidepressant monotherapy is not recommended in bipolar disorder.
-
A benzodiazepine may help sleep for a few nights but does not treat the depressive episode.
-
Venlafaxine carries a relatively high risk of switching into mania and should not be used alone in bipolar disorder.
Show answer and reasoning
Answer: B. Quetiapine as monotherapy
- A. An SSRI alone in a patient with past mania risks a switch into mania and does not treat bipolar depression well.
- B. Her past episode lasted six days with high spending and no need for sleep, which fits bipolar disorder. Quetiapine is a first-line option for bipolar depression in the CANMAT and ISBD guideline.
- C. Bupropion is a first-line drug for unipolar depression, but antidepressant monotherapy is not recommended in bipolar disorder.
- D. A benzodiazepine may help sleep for a few nights but does not treat the depressive episode.
- E. Venlafaxine carries a relatively high risk of switching into mania and should not be used alone in bipolar disorder.
Before treating depression, ask about past mania or hypomania. Bipolar depression needs a mood stabilizing agent such as quetiapine, lurasidone, lithium or lamotrigine, not an antidepressant alone.
Based on: CANMAT and ISBD guidelines for the management of patients with bipolar disorder
Example 2
A 31-year-old woman is brought to the emergency department by her partner 9 days after an uncomplicated vaginal delivery. For three days she has barely slept, laughs and cries without reason, and says the baby has been replaced by an impostor. She is disoriented to date. Temperature 37.0 C, heart rate 92/min, blood pressure 118/74 mm Hg. Her sister has bipolar disorder.
What is the most appropriate next step?
-
Postpartum blues do not cause delusions or disorientation. Reassurance would leave a high-risk mother and baby unprotected.
-
An SSRI is not the treatment for acute psychosis, and a two-week delay is unsafe.
-
The EPDS is a screening tool for depression. The diagnosis here is already clear and urgent.
-
Psychosis with confusion in the first weeks after birth, with a family history of bipolar disorder, is postpartum psychosis. It is an emergency that needs admission and a plan to keep the infant safe.
-
Peer support is useful for postpartum depression but does not address an acute psychotic illness.
Show answer and reasoning
Answer: D. Urgent psychiatric admission, infant kept safe
- A. Postpartum blues do not cause delusions or disorientation. Reassurance would leave a high-risk mother and baby unprotected.
- B. An SSRI is not the treatment for acute psychosis, and a two-week delay is unsafe.
- C. The EPDS is a screening tool for depression. The diagnosis here is already clear and urgent.
- D. Psychosis with confusion in the first weeks after birth, with a family history of bipolar disorder, is postpartum psychosis. It is an emergency that needs admission and a plan to keep the infant safe.
- E. Peer support is useful for postpartum depression but does not address an acute psychotic illness.
Postpartum psychosis is a psychiatric emergency: admit urgently, assess risk to the infant, look for bipolar disorder and medical causes of delirium.
Based on: Standard Canadian perinatal psychiatry practice; MCC Examination Objectives
Example 3
A 38-year-old man has had constant worry about his job, his health and his children for the past 10 months. He sleeps poorly, has neck tension and feels tired. He drinks 2 coffees a day and 2 beers on weekends. He has no history of mania or substance use problems. Examination is normal and TSH is 1.8 mIU/L. He asks for something to help.
What is the most appropriate management?
-
Benzodiazepines are second-line in the Canadian anxiety guideline and long-term daily use risks dependence and cognitive harm.
-
A hypnotic treats one symptom and adds dependence risk without treating the anxiety disorder.
-
Propranolol may help performance anxiety but is not an effective treatment for generalized anxiety disorder.
-
CBT has the strongest evidence among psychotherapies for GAD. Psychodynamic therapy alone is not the first-line choice.
-
This is generalized anxiety disorder. An SSRI such as escitalopram plus CBT are both first-line options.
Show answer and reasoning
Answer: E. Escitalopram with a referral for CBT
- A. Benzodiazepines are second-line in the Canadian anxiety guideline and long-term daily use risks dependence and cognitive harm.
- B. A hypnotic treats one symptom and adds dependence risk without treating the anxiety disorder.
- C. Propranolol may help performance anxiety but is not an effective treatment for generalized anxiety disorder.
- D. CBT has the strongest evidence among psychotherapies for GAD. Psychodynamic therapy alone is not the first-line choice.
- E. This is generalized anxiety disorder. An SSRI such as escitalopram plus CBT are both first-line options.
For GAD, panic and social anxiety, first-line care is CBT and an SSRI or SNRI. Keep benzodiazepines for short-term or second-line use.
Based on: Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
Example 4
A 62-year-old woman with bipolar I disorder, stable on lithium for 8 years, is brought to the emergency department with 3 days of vomiting, diarrhea, coarse tremor and confusion. Her family physician started hydrochlorothiazide 2 weeks ago for hypertension. BP 104/62 mm Hg, HR 98/min. Serum lithium is well above her usual range, creatinine 162 micromoles per litre (baseline 88).
What is the most appropriate next step?
-
She has signs of toxicity with confusion and AKI. A dose reduction with outpatient review is unsafe.
-
An antipsychotic does not treat lithium toxicity and may worsen the neurological picture.
-
Stop the drug and its trigger, restore volume with isotonic fluids, monitor levels and kidney function, and involve nephrology early for possible hemodialysis if severe.
-
Switching drugs and discharging ignores the acute toxicity and the kidney injury.
-
Activated charcoal does not bind lithium, so it is not the treatment.
Show answer and reasoning
Answer: C. Hold lithium and the thiazide, start IV fluids
- A. She has signs of toxicity with confusion and AKI. A dose reduction with outpatient review is unsafe.
- B. An antipsychotic does not treat lithium toxicity and may worsen the neurological picture.
- C. Stop the drug and its trigger, restore volume with isotonic fluids, monitor levels and kidney function, and involve nephrology early for possible hemodialysis if severe.
- D. Switching drugs and discharging ignores the acute toxicity and the kidney injury.
- E. Activated charcoal does not bind lithium, so it is not the treatment.
Lithium toxicity: hold lithium and interacting drugs, give isotonic fluids, monitor levels and creatinine, and consider hemodialysis for severe neurological signs or poor kidney function.
Based on: CANMAT and ISBD bipolar guidelines (lithium monitoring); standard toxicology practice
Example 5
A 46-year-old man is seen in the emergency department after his wife left him. He says he has thought about shooting himself and has a rifle at home. He has stopped working and drinks 8 beers a day. He is not intoxicated now. He says he feels better after talking and wants to go home tonight. He has no psychiatric history.
What is the most appropriate next step?
-
He has a plan, access to a lethal method, recent loss, male sex in middle age and heavy alcohol use. He needs urgent psychiatric assessment, and if he will not stay, the mental health act criteria should be applied.
-
Crisis numbers are part of a discharge plan for low risk, not a substitute for assessment in a high-risk patient.
-
An antidepressant takes weeks to work and does nothing for his immediate risk.
-
No-suicide contracts do not protect patients and are not an accepted safety measure.
-
His alcohol use needs care, but the immediate issue is the risk of suicide with a firearm.
Show answer and reasoning
Answer: A. Hold him for psychiatric assessment under the mental health act
- A. He has a plan, access to a lethal method, recent loss, male sex in middle age and heavy alcohol use. He needs urgent psychiatric assessment, and if he will not stay, the mental health act criteria should be applied.
- B. Crisis numbers are part of a discharge plan for low risk, not a substitute for assessment in a high-risk patient.
- C. An antidepressant takes weeks to work and does nothing for his immediate risk.
- D. No-suicide contracts do not protect patients and are not an accepted safety measure.
- E. His alcohol use needs care, but the immediate issue is the risk of suicide with a firearm.
Plan plus access to lethal means plus risk factors means urgent assessment and a safe setting, even when the patient says he feels better.
Based on: MCC Examination Objectives (suicidal behaviour); provincial mental health acts
Quick recall
Tap a card to turn it over. If you can answer all of them without looking, move on to timed questions.
Where candidates lose marks
- Missing hidden bipolarity
A past few days of no sleep and big spending turns depression into bipolar depression. Antidepressant monotherapy is then the wrong answer.
- Stopping at remission
Feeling better at eight weeks is not the end of treatment. Continue for at least six to twelve months after remission.
- Benzodiazepine reflex
For a new anxiety disorder or PTSD, the long-term benzodiazepine option is a distractor. Choose CBT and an SSRI or SNRI.
- Discharging the intoxicated
A patient voicing suicidal ideas while intoxicated must be reassessed when sober. Do not discharge or dismiss them while impaired.
- Blues vs psychosis
Tearfulness in the first days after birth is blues. Confusion, delusions or bizarre behaviour after delivery is postpartum psychosis and an emergency.
How to study mood & anxiety disorders
Learn the DSM-5-TR duration rules for depression, mania, hypomania, GAD, panic and PTSD until you can recite them.
Read the CANMAT summary tables for depression and bipolar disorder and note the first-line agents and how long to treat.
Practise a suicide risk formulation aloud: risk factors, protective factors, plan, means, and the action you take.
Make a one-page lithium sheet: monitoring, toxicity signs, interacting drugs and what to do first.
Do 40 to 60 mixed mood and anxiety MCQs in this question bank, timed, and review every explanation, including correct ones.
Finish with perinatal cases: blues, depression and psychosis side by side.
Sources and further reading
Check the current edition of each guideline before your exam. This page is study material, not clinical advice.
- MCC Examination Objectives
- CANMAT clinical guidelines for major depressive disorder (2023 update)
- CANMAT and ISBD guidelines for bipolar disorder
- Canadian clinical practice guidelines for anxiety, posttraumatic stress and obsessive-compulsive disorders
- 9-8-8 Suicide Crisis Helpline
- Health Canada: drug and health product safety information